Issuer name: Lifecare ASA
Ex. date: 5 January 2026
Type of corporate action: Partially underwritten preferential rights issue
Other information: The shares in Lifecare ASA will from today, 5 January 2026,
be traded exclusive of the right to receive subscription rights for shares in
the partially underwritten preferential rights issue announced on 22 October
2025.
This information is published in accordance with the requirements of the
Continuing Obligations for companies listed on Euronext Oslo Børs.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-01-05 07:00 CET.